. . .


The following timeline graph is generated from all co-authored publications.

  1. Associations of oral health items of the Vanderbilt Head and Neck Symptom Survey with a dental health assessment. Kolnick L, Deng J, Epstein JB, Migliorati CA, Rezk J, Dietrich MS, Murphy BA (2014) Oral Oncol 50(2): 135-40
    › Primary publication · 24239279 (PubMed)
  2. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Limaye SA, Haddad RI, Cilli F, Sonis ST, Colevas AD, Brennan MT, Hu KS, Murphy BA (2013) Cancer 119(24): 4268-76
    › Primary publication · 24114811 (PubMed)
  3. Assessment of external lymphedema in patients with head and neck cancer: a comparison of four scales. Deng J, Ridner SH, Dietrich MS, Wells N, Murphy BA (2013) Oncol Nurs Forum 40(5): 501-6
    › Primary publication · 23989023 (PubMed)
  4. Body image in patients with head and neck cancer: a review of the literature. Rhoten BA, Murphy B, Ridner SH (2013) Oral Oncol 49(8): 753-60
    › Primary publication · 23683468 (PubMed)
  5. Caregiver-reported neuropsychiatric symptoms in patients undergoing treatment for head and neck cancer: a pilot study. Bond SM, Hawkins DK, Murphy BA (2014) Cancer Nurs 37(3): 227-35
    › Primary publication · 23619332 (PubMed) · PMC4304699 (PubMed Central)
  6. Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life. Deng J, Murphy BA, Dietrich MS, Wells N, Wallston KA, Sinard RJ, Cmelak AJ, Gilbert J, Ridner SH (2013) Head Neck 35(7): 1026-35
    › Primary publication · 22791550 (PubMed) · PMC4017911 (PubMed Central)
  7. Advanced pneumatic therapy in self-care of chronic lymphedema of the trunk. Ridner SH, Murphy B, Deng J, Kidd N, Galford E, Dietrich MS (2010) Lymphat Res Biol 8(4): 209-15
    › Primary publication · 21190493 (PubMed) · PMC3008167 (PubMed Central)
  8. Cancer pain management in ambulatory care: can we link assessment and action to outcomes? Wells N, McDowell MR, Hendricks P, Dietrich MS, Murphy B (2011) Support Care Cancer 19(11): 1865-71
    › Primary publication · 21052733 (PubMed) · PMC3103757 (PubMed Central)
  9. Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma. Hatakeyama H, Cheng H, Wirth P, Counsell A, Marcrom SR, Wood CB, Pohlmann PR, Gilbert J, Murphy B, Yarbrough WG, Wheeler DL, Harari PM, Guo Y, Shyr Y, Slebos RJ, Chung CH (2010) PLoS One 5(9): e12702
    › Primary publication · 20856931 (PubMed) · PMC2938338 (PubMed Central)
  10. Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients. Chung CH, Seeley EH, Roder H, Grigorieva J, Tsypin M, Roder J, Burtness BA, Argiris A, Forastiere AA, Gilbert J, Murphy B, Caprioli RM, Carbone DP, Cohen EE (2010) Cancer Epidemiol Biomarkers Prev 19(2): 358-65
    › Primary publication · 20086114 (PubMed) · PMC2846615 (PubMed Central)